Atea Pharmaceuticals Inc (NASDAQ: AVIR) kicked off on Tuesday, up 8.20% from the previous trading day, before settling in for the closing price of $3.17. Over the past 52 weeks, AVIR has traded in a range of $2.45-$4.02.
Healthcare Sector giant saw their annual sales slid by -63.72% over the last five years. While this was happening, its average annual earnings per share was recorded 13.75%. With a float of $62.12 million, this company’s outstanding shares have now reached $78.13 million.
The firm has a total of 56 workers. Let’s measure their productivity.
Atea Pharmaceuticals Inc (AVIR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atea Pharmaceuticals Inc is 20.49%, while institutional ownership is 65.03%.
Atea Pharmaceuticals Inc (AVIR) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.4 earnings per share (EPS), lower than consensus estimate (set at -0.29) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.77% during the next five years compared to -63.72% drop over the previous five years of trading.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Trading Performance Indicators
Take a look at Atea Pharmaceuticals Inc’s (AVIR) current performance indicators. Last quarter, stock had a quick ratio of 16.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Atea Pharmaceuticals Inc (AVIR)
Analysing the last 5-days average volume posted by the [Atea Pharmaceuticals Inc, AVIR], we can find that recorded value of 0.49 million was better than the volume posted last year of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 53.11%.
During the past 100 days, Atea Pharmaceuticals Inc’s (AVIR) raw stochastic average was set at 60.19%, which indicates a significant decrease from 97.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.11 in the past 14 days, which was lower than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.17, while its 200-day Moving Average is $3.18. Now, the first resistance to watch is $3.52. This is followed by the second major resistance level at $3.60. The third major resistance level sits at $3.77. If the price goes on to break the first support level at $3.27, it is likely to go to the next support level at $3.10. Should the price break the second support level, the third support level stands at $3.02.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Key Stats
The company with the Market Capitalisation of 267.97 million has total of 78,127K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -168,390 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -42,050 K.
